421 related articles for article (PubMed ID: 31928364)
1. A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome.
Retallick-Brown H; Blampied N; Rucklidge JJ
J Altern Complement Med; 2020 Feb; 26(2):88-97. PubMed ID: 31928364
[No Abstract] [Full Text] [Related]
2. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
3. Study Protocol for a Randomized Double Blind, Treatment Control Trial Comparing the Efficacy of a Micronutrient Formula to a Single Vitamin Supplement in the Treatment of Premenstrual Syndrome.
Retallick-Brown H; Rucklidge J; Blampied N
Medicines (Basel); 2016 Dec; 3(4):. PubMed ID: 28930142
[No Abstract] [Full Text] [Related]
4. Efficacy of the Flo App in Improving Health Literacy, Menstrual and General Health, and Well-Being in Women: Pilot Randomized Controlled Trial.
Cunningham AC; Prentice C; Peven K; Wickham A; Bamford R; Radovic T; Klepchukova A; Fomina M; Cunningham K; Hill S; Hantsoo L; Payne J; Zhaunova L; Ponzo S
JMIR Mhealth Uhealth; 2024 May; 12():e54124. PubMed ID: 38696773
[TBL] [Abstract][Full Text] [Related]
5. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
[TBL] [Abstract][Full Text] [Related]
7. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
Svojanovská K
Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
[TBL] [Abstract][Full Text] [Related]
8. Frequency, intensity and impact of premenstrual syndrome in medical students.
Nisar N; Zehra N; Haider G; Munir AA; Sohoo NA
J Coll Physicians Surg Pak; 2008 Aug; 18(8):481-4. PubMed ID: 18798584
[TBL] [Abstract][Full Text] [Related]
9. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
10. Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorder in Adolescent Athletes.
Czajkowska M; Drosdzol-Cop A; Gałązka I; Naworska B; Skrzypulec-Plinta V
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):492-8. PubMed ID: 26233292
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
[TBL] [Abstract][Full Text] [Related]
12. Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
Henz A; Ferreira CF; Oderich CL; Gallon CW; Castro JRS; Conzatti M; Fleck MPA; Wender MCO
Rev Bras Ginecol Obstet; 2018 Jan; 40(1):20-25. PubMed ID: 29132173
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial.
Ramos MG; Hara C; Rocha FL
Int J Neuropsychopharmacol; 2009 Sep; 12(8):1081-8. PubMed ID: 19250561
[TBL] [Abstract][Full Text] [Related]
14. Differences in symptom scores and health outcomes in premenstrual syndrome.
Borenstein JE; Dean BB; Leifke E; Korner P; Yonkers KA
J Womens Health (Larchmt); 2007 Oct; 16(8):1139-44. PubMed ID: 17937566
[TBL] [Abstract][Full Text] [Related]
15. Predictors of response to sertraline treatment of severe premenstrual syndromes.
Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
Freeman EW
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
[TBL] [Abstract][Full Text] [Related]
17. [Premenstrual syndrome and premenstrual dysphoric disorder].
Kovács Z; Hegyi G; Szőke H
Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
[TBL] [Abstract][Full Text] [Related]
18. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review.
Whelan AM; Jurgens TM; Naylor H
Can J Clin Pharmacol; 2009; 16(3):e407-29. PubMed ID: 19923637
[TBL] [Abstract][Full Text] [Related]
19. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
Yang J; Joe SH; Lee MS; Kim SH; Jung IK
Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial Profile of Women with Premenstrual Syndrome and Healthy Controls: A Comparative Study.
Kleinstäuber M; Schmelzer K; Ditzen B; Andersson G; Hiller W; Weise C
Int J Behav Med; 2016 Dec; 23(6):752-763. PubMed ID: 27151401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
